Targeting tumor acidity pathway may overcome PARP inhibitor resistance in ovarian cancer. Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely used treatment.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely used treatment.
- Ponto de atenção: targeting.
- Ponto de atenção: tumor.
- Ponto de atenção: acidity.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
Acompanhe a Recifes.net
Entre no Canal do WhatsApp da Recifes.net para receber noticias, bastidores e atualizacoes editoriais diretamente no WhatsApp.
